Clinical Trial Update: Fasting on Newly Diagnosed Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating fasting in newly diagnosed HER2-positive breast cancer was terminated, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Western Regional Medical Center | Conditions: HER2-positive Breast Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-11-08